{
    "2019-04-16": [
        [
            {
                "time": "2019-04-17",
                "original_text": "A股头条之上市公司公告精选（4.17）",
                "features": {
                    "keywords": [
                        "上市公司",
                        "公告",
                        "精选"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "上市公司业绩精选：恒瑞医药一季度净利11.9亿元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "一季度",
                        "净利",
                        "11.9亿"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "恒瑞医药(600276.SH)一季度净利润升25.61%至11.93亿元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "一季度",
                        "净利润",
                        "增长",
                        "25.61%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "恒瑞医药：一季度净利11.93亿元 同比增26%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "一季度",
                        "净利",
                        "增长",
                        "26%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "恒瑞医药一季报：一季度净利11.93亿元，同比增长25.61%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "一季报",
                        "净利",
                        "增长",
                        "25.61%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "外强中干的太极集团",
                "features": {
                    "keywords": [
                        "太极集团",
                        "外强中干"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "93个重点产品中标价与医疗机构采购量曝光",
                "features": {
                    "keywords": [
                        "重点产品",
                        "中标价",
                        "采购量",
                        "曝光"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "“4+7”带量采购政策下的行业发展机遇",
                "features": {
                    "keywords": [
                        "4+7",
                        "带量采购",
                        "政策",
                        "机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "2018医药生物企业成绩单出炉，整体表现良好",
                "features": {
                    "keywords": [
                        "医药生物",
                        "成绩单",
                        "整体表现",
                        "良好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "恒瑞系老板娘掌舵，高瓴博裕入场站队，年内最重磅医药IPO来了",
                "features": {
                    "keywords": [
                        "恒瑞系",
                        "老板娘",
                        "高瓴博裕",
                        "IPO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "[天风医药] 贝达药业：埃克替尼销量高速增长，新品种步入收获期有望迎来业绩拐点",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "销量",
                        "增长",
                        "新品种",
                        "业绩拐点"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "[天风医药] 片仔癀：2018年业绩实现高增长，2019年有望延续良好的发展态势",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "2018年",
                        "业绩",
                        "高增长",
                        "2019年",
                        "延续"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "[天风医药] 健帆生物：一季度维持高增长，业绩实现开门红",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "一季度",
                        "高增长",
                        "开门红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-16",
                "original_text": "[招商策略] 年初以来全球市场走势背后的科技趋势——观策天夏第九话（0416）",
                "features": {
                    "keywords": [
                        "全球市场",
                        "走势",
                        "科技趋势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}